Skip to content
Riskpilot
← Tilbage til søgning
Log ind
Få fuld adgang
Creative MedPharm Sweden AB
AB
Active
Org 5591558233
Hörlanders Väg 11, 212 36
Malmö
Wholesale of pharmaceutical and medical goods
· NACE 4646
Est. 2018
1 employees
Watchlist
Share
Sweden
/
Companies
/
Wholesale of pharmaceutical and medical goods
/
Creative MedPharm Sweden AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
SEK thousands
Item
2021
2022
2023
2024
2025
Revenue
177
254
101
104
27
Staff expenses
—
—
−7
−7
−6
EBITDA
−253
−65
19
−50
−62
Depreciation & amort.
−0
−0
—
—
—
EBIT
−253
−65
19
−50
−62
Net financials
—
—
−0
0
0
Profit before tax
−139
−65
19
−50
−62
Tax
−0
−0
—
—
—
Net profit
−139
−65
19
−50
−62
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
2025
Total assets
327
276
288
245
168
Equity
315
250
268
218
156
Long-term debt
0
0
—
—
—
Short-term debt
12
26
20
27
11
Total debt
12
26
20
27
11
Financial ratios
5-year trend
EBITDA-margin
-232.3%
This company
15.8%
Market median
-1570% vs market
2021
2025
Soliditetsgrad
93.4%
This company
38.2%
Market median
+145% vs market
2021
2025
Egenkapitalforrentning
-39.5%
This company
18.4%
Market median
-315% vs market
2021
2025
Nettoresultatgrad
-232.2%
This company
8.1%
Market median
-2967% vs market
2021
2025
Aktivomsætning
0.16×
This company
1.12×
Market median
-86% vs market
2021
2025
Gæld/egenkapital
0.07×
This company
0.62×
Market median
+89% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via Bolagsverket / SCB · Period 2024-02-01 – 2025-01-31
View
PDF
Annual report 2024
Filed via Bolagsverket / SCB · Period 2023-02-01 – 2024-01-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2022-02-01 – 2023-01-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2021-02-01 – 2022-01-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-02-01 – 2021-01-31
View
PDF
More on Creative MedPharm Sweden AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
